In a Jan. 14, 1914, editorial, the editors of Druggist Circular, the precursor of Drug Topics, made their position quite clear on the pending Harrison Narcotic Act. "Perhaps the narcotic evil has been the most absorbing single topic among druggists," the editors insisted. "Inaction [on the bill] was a disappointment to the drug trade, which ... has agreed upon the terms." The magazine need not have worried. The act, which aimed to regulate and control the distribution of opium- and cocaine-derived medications, passed later in 1914 and augured a new era for pharmacies of government monitoring and restrictions on certain classes of medications.
Editor's note: Throughout 2007, this column, which takes a look at some of the most important moments in the history of pharmacy, will appear in each issue as part of our sesquicentennial celebration. Tied with this column is a pharmacy history contest, which we are urging all readers to participate in. Monthly questions based on this column will be posted on the Drug Topics anniversary microsite. Contestants are eligible to win a Visa gift card of $250. For details about the contest, go to http://www.drugtopics.com/drugtopics/form/formDetail.jsp?formId=395300
In a Jan. 14, 1914, editorial, the editors of Druggist Circular, the precursor of Drug Topics, made their position quite clear on the pending Harrison Narcotic Act. "Perhaps the narcotic evil has been the most absorbing single topic among druggists," the editors insisted. "Inaction [on the bill] was a disappointment to the drug trade, which ... has agreed upon the terms." The magazine need not have worried. The act, which aimed to regulate and control the distribution of opium- and cocaine-derived medications, passed later in 1914 and augured a new era for pharmacies of government monitoring and restrictions on certain classes of medications.
It was not always this way. In 1886 the magazine ran 35 articles featuring uses of cocaine. In fact, well into the 20th century a broad range of narcotics was widely available at pharmacies. As early as 1901, the American Pharmaceutical Association commissioned a committee to investigate addictive medications available at pharmacies. According to historian Glenn Sonnedecker, the committee was "appalled" by what it found. Numerous states passed laws, but increasingly pharmacists looked to the federal government for oversight and uniform enforcement.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.